Patents

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2012/0093763 RNA VIRUS INFECTION INHIBITOR, METHOD FOR INHIBITION OF INFECTION BY RNA VIRUS, RNA VIRUS INFECTION-INHIBITING...
Disclosed herein is an RNA virus infection inhibitor that is capable of effectively inhibiting humans from being infected with RNA viruses to prevent the...
2012/0093762 NUCLEIC ACID DELIVERY COMPOUNDS
Polymers including two or more different recurring units are disclosed herein. Also disclosed herein are methods of using such polymers to deliver nucleic acids...
2012/0093761 VACCINE COMPOSITIONS AND METHODS OF USE THEREOF
Nanoparticle-based vaccines, compositions, kits and methods are used for the effective delivery of one or more antigens in vivo for vaccination and antibody...
2012/0093760 POLYQUATERNIUM-1 SYNTHESIS METHODS
The present embodiments relate to a novel method of making quaternary ammonium polymers comprising the steps of: a) mixing 1,4-bis-dimethylamino-2-butene,...
2012/0093759 Medical Devices, Wound Dressings, and Methods for Dressing Wounds
Medical devices, wound dressings, and methods of dressing wounds are described. Devices and methods using silicone and pharmaceutically active agents are...
2012/0093758 Hair Cosmetic
The present invention provides a hair cosmetic composition contains (A) a di-long-chain cationic surfactant represented by formula (1); (B) an ethylene oxide...
2012/0093757 COMPOSITION
Hair conditioner comprising silicone and a conditioning gel phase, said phase obtainable by heating a fatty alcohol and an oil until they are molten, separately...
2012/0093756 CONCENTRATED SHAMPOO
Concentrated shampoo composition comprising from 27 to 70% wt. cleansing surfactant, a conditioning gel phase, a short chain diol and an oil, wherein the...
2012/0093755 COMPOSITIONS AND METHODS FOR TREATING KERATIN BASED FIBERS
Compositions, formulations, kits and methods for temporarily or semi-permanently transforming the shape of individual hair filaments or keratinous fibers...
2012/0093754 Conditioning Composition for Keratin Fibres
The present invention relates to a conditioning composition for keratin fibres especially human hair comprising particular cationic cellulose polymer and a...
2012/0093753 CATIONIC POLYGLYCERYL COMPOSITIONS AND COMPOUNDS
Provided are polyglyceryl compositions comprising one or more polyglyceryl compounds having: (a) a node structure comprising at least three contiguous glyceryl...
2012/0093752 Use of Monoamine Oxidase Inhibitors to Improve Epithelial Biology
The invention provides a method for improving hair biology, e.g., hair growth. The method comprises administering to a subject a monoamine oxidase inhibitor and...
2012/0093751 Hair Cosmetic
To provide means for improving tactile sensation of hair during application of a hair cosmetic composition, particularly a hair conditioner or a hair rinse,...
2012/0093750 COSMETIC COMPOSITION MADE FROM ION-EXCHANGE RESINS FILLED WITH LIPOAMINOACIDS
Disclosed is a composition of ion-exchange resins made from a styrene-divinylbenzene copolymer or an acrylic-divinylbenzene copolymer filled with at least one...
2012/0093749 USE OF DELTA-TOCOPHERYL-CARBOHYDRATE AS A DEPIGMENTING AGENT
The present invention relates to a cosmetic or pharmaceutical composition for cutaneous application, whose goal is the depigmentation of the skin.
2012/0093748 TOPICAL PERSONAL CARE AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
Topical compositions are provided that have 0.5% or more of at least one personal care or pharmaceutical acid, and lightly- to moderately-crosslinked PVP, which...
2012/0093747 SUNSCREEN COSMETIC COMPOSITION CONTAINING ULTRAVIOLET ABSORBER
A sunscreen cosmetic composition contains an ultraviolet absorber composed of a triazine compound (a) represented by the general formula (1) below and a...
2012/0093746 AMINO ACID-MODIFIED ORGANOPOLYSILOXANE, MAKING METHOD, AND COSMETICS
An amino acid-modified organopolysiloxane can be prepared under mild reaction conditions by reacting an amino-modified organopolysiloxane with an amino acid or...
2012/0093745 PEPTIDIC HYDROLYZATE PROTEASOME ACTIVATORS AND COMPOSITIONS CONTAINING SAME
The present invention concerns a peptidic hydrolyzate enriched in bioactive peptides, said hydrolyzate being a proteasome activator. Further, the present...
2012/0093744 MODIFIED OILS AND MULTIPLE EMULSIONS
According to one aspect, the present invention relates to the use of a perfluoropolyether phosphate (PFPE phosphate), dissolved in water, for the preparation of...
2012/0093743 ADDITION OF FLUORIDE TO BEVERAGES
A system and method for preventing tooth decay comprises steps or acts of adding a small dose of fluoride to a carbonated or sugar-containing beverage to...
2012/0093742 Compounds
A method of modulating the flavour of an orally-receivable product, such as a foodstuff, beverage, dentifrice or medicine, comprising the addition thereto of a...
2012/0093741 DENTAL MASKING COMPOUND
A photopolymerizable dental composition for application to and for the isolation and protection of gums and/or teeth during dental treatment is described. The...
2012/0093740 PEPTIDE FRAGMENTS FOR INDUCING SYNTHESIS OF EXTRACELLULAR MATRIX PROTEINS
Short biologically active tetrapeptides are disclosed that are comprised of the sequences GxxG and PxxP where G (glycine) and P (proline) are maintained and x...
2012/0093739 METHOD FOR TREATING HAIR GROWTH DISORDERS, SUCH AS FEMALE PATTERN ALOPECIA, AND COMPOSITIONS USEFUL THEREFORE
The invention relates to formulations useful in treating hair disorders, improving the health of hair, increasing hair growth, and in increasing the niacin...
2012/0093738 TASTE-MASKED ORAL FORMULATIONS OF INFLUENZA ANTIVIRALS
The present invention relates to taste-masked oral formulations of influenza antivirals. The taste-masked pharmaceutical formulations for oral administration...
2012/0093737 LIGHT-ABSORBING COMPOSITIONS AND METHODS OF USE
The present disclosure relates to methods and compositions comprising naturally occurring light absorbing molecules for preventing damages from light exposure....
2012/0093736 REVERSIBLE COLOR-CHANGING INK FORMULATIONS AND NONWOVEN WIPES
A reversible color-changing ink formulation, and a nonwoven wipe to which the ink formulation is securely bound, are provided. The reversible color-changing ink...
2012/0093735 COMPLEX COMPOUND AND MRI PROBE MADE OF SAME
Novel gadolinium complex compounds responsive to ions and compounds other than zinc ion, as well as MRI probes made of the compounds are disclosed. Since the...
2012/0093734 PROTEIN-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF COLORECTAL ADENOCARCINOMA
Protein-based methods and compositions for the diagnosis of colorectal adenocarcinoma are disclosed. A method for identifying cell-surface proteins, which are...
2012/0093733 MULTIDOMAIN BIOTAGS FOR CANCER DETECTION, DIAGNOSIS AND THERAPY AND METHODS OF THEIR USE
In one embodiment, a biotag for targeting a cancer biomarker is provided. The biotag may include a cancer biomarker binding domain, an internalization domain,...
2012/0093732 ULTRASOUND CONTRAST AGENTS AND METHODS OF MAKING AND USING THEM
The invention is directed to injectable suspensions of gas-filled microvesicles, as well as methods of preparing and using the same, especially as ultrasound...
2012/0093731 GAS-FILLED MICROVESICLES WITH TARGETING LIGAND OR THERAPEUTIC AGENT
Gas-filled microvesicles comprising a boundary envelope containing a gas, wherein said microvesicles comprise: --a first component, bound to said envelope,...
2012/0093730 MOLECULAR DEATH TAGS AND METHODS OF THEIR USE
In one embodiment, a death tag for targeting a cell death marker is provided, the death tag comprising a death marker binding domain; a reporter binding domain...
2012/0093729 NOVEL PHOSPHORUS-CONTAINING PRODRUGS
Novel cyclic phosphoramidate prodrugs of drugs of formula I ##STR00001## their use in delivery of drugs to the liver, their use in enhancing oral bioavailability,...
2012/0093728 MITOCHONDRIAL INHIBITORS TO TREAT HUMAN DISEASE
The present invention relates to inhibitors of mitochondria-associated, granulocyte-macrophage colony stimulating factor signaling molecule (Magmas), and...
2012/0093727 COMPOSITIONS AND METHODS FOR IN VIVO IMAGING OF MYELIN IN THE PERIPHERAL NERVOUS SYSTEM
A method of detecting and/or labeling myelin in an animal's peripheral nervous system tissue includes administering to the animal a fluorescent stilbenzene...
2012/0093726 Radiolabeled Fluorine Derivatives of Methionine
The invention provides compound which is an .sup.18F-radiolabelled S-propylhomocysteine or a derivative thereof. The compound has an enantiomeric purity of at...
2012/0093725 Fucoidans as Ligands for the Diagnosis of Degenerative Pathologies
The present invention relates to the diagnosis of clinical conditions characterized by undesirable and/or abnormal selectin expression. In particular, the...
2012/0093724 METHODS AND COMPOSITIONS FOR THE DETECTION OF CANCER
Various embodiments of this invention relate generally to targeted activation and delivery of therapeutic drugs to cells that produce prostate specific antigen...
2012/0093723 NANOCARRIER COMPOSITIONS AND METHODS
This invention provides multimeric nanocarrier for in vivo delivery of a bioactive agent, comprising at least two peptide monomers reversibly or irreversibly...
2012/0093722 SYNTHETIC DIBLOCK COPOLYPEPTIDE HYDROGELS FOR USE IN THE CENTRAL NERVOUS SYSTEM
This invention relates, e.g., to a composition suitable for administration to the central nervous system (CNS), comprising a block copolypeptide hydrogel, which...
2012/0093721 USES OF CANCER-TARGETING PEPTIDES IN CANCER DIAGNOSIS
Cancer-targeting peptides and uses thereof in cancer diagnosis.
2012/0093720 Molecularly Imprinted Polymers for Use as Imaging and Therapeutics Agents
The invention described herein provides biocompatible molecularly imprinted polymers (MIPs) that are non-toxic, water soluble, small molecular weight, and...
2012/0093719 ANTIBODIES AGAINST PROSTATE SPECIFIC MEMBRANE ANTIGEN
Antibodies (Ab) and antigen binding fragments capable of binding to prostate specific membrane antigen and which may be used for diagnostic and therapeutic...
2012/0093718 LIPOSOMAL NANOPARTICLES AND OTHER FORMULATIONS OF FENRETINIDE FOR USE IN THERAPY AND DRUG DELIVERY
Formulations of neutral retinoids, in particular fenretinide (HPR) in the form of lipid nanoparticles, solid dipersions and emulsions are disclosed. These...
2012/0093717 MICROSPHERE/NANOFIBER COMPOSITES FOR DELIVERY OF DRUGS, GROWTH FACTORS, AND OTHER AGENTS
Provided are compositions that include polymeric fibers and microspheres entrapped within the fibers, the compositions being capable of controlled delivery of...
2012/0093716 USE OF ANTISECRETORY FACTORS (AF) FOR OPTIMIZING CELLULAR UPTAKE
The present invention relates to the use of an antisecretory factor (AF) protein, peptide, derivative, homologue, and/or fragment thereof, having equivalent...
2012/0093715 MONOLITHIC ZEOLITE STRUCTURES WITH AND WITHOUT HIERARCHICAL PORE STRUCTURES AND METHODS FOR PRODUCING THE SAME
Monolithic zeolite structures with hierarchical pore structures and methods for producing monolithic zeolite structures without the use of a solid template are...
2012/0093714 High-Capacity Complex Hydrogen Storage Materials and a Process of Releasing Hydrogen
Disclosed herein provide compositions and hydrogen release methods for a high-capacity complex hydrogen storage material. The hydrogen storage material is...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 | Next →